Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial

1. Das, R.
2. Blázquez-Gamero, D.
3. Bernstein, D.I.
4. Gantt, S.
5. Bautista, O.
6. Beck, K.
7. Conlon, A.
8. Rosenbloom, D.I.S.
9. Wang, D.
10. Ritter, M.
11. Arnold, B.
12. Annunziato, P.
13. Russell, K.L.